Dr. Juan Camilo Arjona Ferreira - 11 Aug 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol
OGN
Transactions as of
11 Aug 2024
Net transactions value
-$80,419
Form type
4
Filing time
12 Aug 2024, 17:18:14 UTC
Previous filing
16 Apr 2024
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +11,519 +86285% $0.000000 11,532 11 Aug 2024 Direct
transaction OGN Common Stock Tax liability $80,419 -3,991 -35% $20.15 7,541 11 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -11,519 -33% $0.000000 23,038 11 Aug 2024 Common Stock 11,519 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Organon common stock.
F2 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments of 11,519 shares on each of August 11, 2024; August 11, 2025; and August 11, 2026.